Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Condition: Esophageal Adenocarcinoma Interventions: Drug: Pembrolizumab; Drug: Taxol; Drug: Carboplatin Sponsor: Weill Medical College of Cornell University Not yet recruiting - verified December 2016
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου